Shenzhen New Industries Biomedical Engineering Co., Ltd. (SHE:300832)
China flag China · Delayed Price · Currency is CNY
48.43
-1.75 (-3.49%)
May 14, 2026, 3:04 PM CST

SHE:300832 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
38,05244,19755,66861,44339,41634,652
Market Cap Growth
-8.19%-20.61%-9.40%55.88%13.75%-36.36%
Enterprise Value
35,63341,94153,08758,19636,45031,451
Last Close Price
48.4356.2569.2775.4647.8041.41
PE Ratio
23.4227.2830.4537.1629.6835.59
Forward PE
20.3724.3025.2331.0227.8328.70
PS Ratio
8.319.6612.2715.6412.9413.61
PB Ratio
4.014.836.498.146.166.18
P/TBV Ratio
4.114.966.688.336.336.28
P/FCF Ratio
25.0336.5060.6956.0670.4980.54
P/OCF Ratio
20.4329.0341.0443.3240.9644.82
EV/Sales Ratio
7.789.1611.7114.8111.9612.36
EV/EBITDA Ratio
17.6721.3525.1230.8225.2327.32
EV/EBIT Ratio
19.6023.6627.4733.4827.3529.74
EV/FCF Ratio
23.4434.6357.8853.0965.1973.10
Debt / Equity Ratio
0000.0000
Debt / EBITDA Ratio
0.000.000.000.000.000.00
Debt / FCF Ratio
0.000.000.000.010.000.01
Net Debt / Equity Ratio
-0.25-0.36-0.31-0.45-0.53-0.61
Net Debt / EBITDA Ratio
-1.20-1.70-1.25-1.80-2.36-2.97
Net Debt / FCF Ratio
-1.59-2.75-2.88-3.10-6.09-7.95
Asset Turnover
0.460.470.510.520.460.45
Inventory Turnover
1.231.261.201.211.221.33
Quick Ratio
6.067.234.136.966.737.31
Current Ratio
10.548.985.568.568.268.85
Return on Equity (ROE)
17.57%18.29%22.68%23.72%22.11%18.70%
Return on Assets (ROA)
11.39%11.33%13.54%14.26%12.67%11.55%
Return on Invested Capital (ROIC)
24.56%26.36%33.48%42.54%45.48%50.08%
Return on Capital Employed (ROCE)
18.80%19.10%22.20%22.80%20.70%18.80%
Earnings Yield
4.27%3.67%3.28%2.69%3.37%2.81%
FCF Yield
3.99%2.74%1.65%1.78%1.42%1.24%
Dividend Yield
2.39%2.13%1.88%1.32%1.47%1.45%
Payout Ratio
62.89%63.07%42.98%33.15%35.53%42.46%
Buyback Yield / Dilution
0.00%-0.00%0.01%0.07%-0.04%-4.76%
Total Shareholder Return
2.42%2.13%1.89%1.39%1.42%-3.31%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.